Clinical Trial Update: Study to Learn About How the Study Medicines Called PF-07976016 and PF-06882961 Are Taken Up by the Body, and if Either of Them Change How the Body Processes the Other Medicine in Otherwise Healthy Adults With Overweight or Obesity [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study to characterize how PF-07976016 and PF-06882961 are absorbed and whether they affect each other’s metabolism in otherwise healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• PF-06882961
• PF-07976016

Snippet

Sponsor: Pfizer | Conditions: Overweight, Obesity | Phase 1 | Status: TERMINATED